BHVN
Biohaven Ltd.Recent alerts on BHVN
All signals →
SEC filing
BHVN Reports Opakalim 3x Seizure Delay, 54% Responder Rate, Zero CNS AEs in Epilepsy Trials
5d ago
News
Why Biohaven Stock Zoomed More Than 6% Higher Today
14d ago
News
Why Biohaven Stock Dove by Nearly 20% on Thursday
14d ago
News
Why Biohaven Stock Plummeted by More Than 15% Today
14d ago
News
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
14d ago
News
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
14d ago
News
Why Biohaven Stock Triumphed on Tuesday
14d ago
News
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
14d ago
News
Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
14d ago
News
Biohaven GAAP EPS of -$0.88 misses by $0.04
28d ago
SEC filing
BHVN Reports $12M Q1 Revenue, $0.05 EPS, Updates Pipeline: Opakalim 2H26 Data, Taldefgrobep 2H26, BHV-1400/BHV-1300 Pivotal 2H26, BHV-1530 Escalation, 5 AAN Abstracts
28d ago
SEC filing
BHVN Votes For Directors Heffernan 76.1M Antonijevic 76.6M Hugin 76.6M Ratifies EY Auditors 123.7M Advisory Vote Compensation 87.5M Approved
28d ago
News
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential
70d ago
Insider trade
Purchase by CHILDS JOHN W
84d ago
Short volume
Short volume 74% of volume (3.4σ)
115d ago
News
ClearBridge Small-Cap Growth trims Duolingo, Biohaven, QLYS; Adds PTGX, SSD, BETA, DYN in Q4
131d ago
News
CannaLean Biotechs Announces Positive Completion of First-in-Human Feasibility Study of Its Novel CBD-Based Lipid-Lowering Therapy
133d ago
News
CMS Transitional Pass-Through Payment (TPT) description for HCPCS code C1741 has been revised
137d ago
News
Bexorg Raises $42.5M to Transform CNS Drug Development with World’s First Integrated AI and Whole-Human Brain Platform
153d ago
Get push alerts for BHVN
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS